• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR/Cas9系统提供的新型表观遗传技术。

Novel Epigenetic Techniques Provided by the CRISPR/Cas9 System.

作者信息

Xie Nina, Zhou Yafang, Sun Qiying, Tang Beisha

机构信息

Department of Geriatric Neurology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

National Clinical Research Center for Geriatric Disorders, Central South University, Changsha, Hunan 410078, China.

出版信息

Stem Cells Int. 2018 Jul 8;2018:7834175. doi: 10.1155/2018/7834175. eCollection 2018.

DOI:10.1155/2018/7834175
PMID:30123293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6079388/
Abstract

Epigenetics classically refers to the inheritable changes of hereditary information without perturbing DNA sequences. Understanding mechanisms of how epigenetic factors contribute to inheritable phenotype changes and cell identity will pave the way for us to understand diverse biological processes. In recent years, the emergence of CRISPR/Cas9 technology has provided us with new routes to the epigenetic field. In this review, novel epigenetic techniques utilizing the CRISPR/Cas9 system are the main contents to be discussed, including epigenome editing, temporal and spatial control of epigenetic effectors, noncoding RNA manipulation, chromatin in vivo imaging, and epigenetic element screening.

摘要

表观遗传学传统上是指在不干扰DNA序列的情况下遗传信息的可遗传变化。了解表观遗传因素如何导致可遗传的表型变化和细胞特性的机制,将为我们理解各种生物学过程铺平道路。近年来,CRISPR/Cas9技术的出现为我们进入表观遗传学领域提供了新途径。在这篇综述中,利用CRISPR/Cas9系统的新型表观遗传技术是主要讨论内容,包括表观基因组编辑、表观遗传效应因子的时空控制、非编码RNA操作、染色质体内成像以及表观遗传元件筛选。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0655/6079388/fa192c7a9103/SCI2018-7834175.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0655/6079388/1c06b765b709/SCI2018-7834175.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0655/6079388/ab0594040f60/SCI2018-7834175.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0655/6079388/4c5f127f752a/SCI2018-7834175.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0655/6079388/fa192c7a9103/SCI2018-7834175.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0655/6079388/1c06b765b709/SCI2018-7834175.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0655/6079388/ab0594040f60/SCI2018-7834175.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0655/6079388/4c5f127f752a/SCI2018-7834175.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0655/6079388/fa192c7a9103/SCI2018-7834175.004.jpg

相似文献

1
Novel Epigenetic Techniques Provided by the CRISPR/Cas9 System.CRISPR/Cas9系统提供的新型表观遗传技术。
Stem Cells Int. 2018 Jul 8;2018:7834175. doi: 10.1155/2018/7834175. eCollection 2018.
2
CRISPR/Cas9-mediated noncoding RNA editing in human cancers.CRISPR/Cas9 介导的人类癌症中非编码 RNA 编辑。
RNA Biol. 2018 Jan 2;15(1):35-43. doi: 10.1080/15476286.2017.1391443. Epub 2017 Nov 9.
3
Editing the Epigenome: Reshaping the Genomic Landscape.编辑表观基因组:重塑基因组景观。
Annu Rev Genomics Hum Genet. 2018 Aug 31;19:43-71. doi: 10.1146/annurev-genom-083117-021632. Epub 2018 May 31.
4
CRISPR-Mediated Epigenome Editing.CRISPR介导的表观基因组编辑
Yale J Biol Med. 2016 Dec 23;89(4):471-486. eCollection 2016 Dec.
5
Recent Progress in CRISPR/Cas9 Technology.CRISPR/Cas9技术的最新进展
J Genet Genomics. 2016 Feb 20;43(2):63-75. doi: 10.1016/j.jgg.2016.01.001. Epub 2016 Jan 18.
6
Advanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the Brain.CRISPR/Cas9和反义DNA抑制在脑内基因操纵中的体内高级应用
Front Genet. 2016 Jan 12;6:362. doi: 10.3389/fgene.2015.00362. eCollection 2015.
7
Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing.锌指蛋白、转录激活样效应因子及CRISPR系统:表观基因组编辑工具比较
Methods Mol Biol. 2018;1767:19-63. doi: 10.1007/978-1-4939-7774-1_2.
8
CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.基于 CRISPR/Cas9 的表观基因组编辑:dCas9 工具概述,特别强调脱靶活性。
Methods. 2019 Jul 15;164-165:109-119. doi: 10.1016/j.ymeth.2019.05.003. Epub 2019 May 6.
9
CRISPR/Cas9-loxP-Mediated Gene Editing as a Novel Site-Specific Genetic Manipulation Tool.CRISPR/Cas9-loxP介导的基因编辑作为一种新型的位点特异性基因操作工具。
Mol Ther Nucleic Acids. 2017 Jun 16;7:378-386. doi: 10.1016/j.omtn.2017.04.018. Epub 2017 Apr 25.
10
Epigenome Editing: State of the Art, Concepts, and Perspectives.表观基因组编辑:现状、概念和展望。
Trends Genet. 2016 Feb;32(2):101-113. doi: 10.1016/j.tig.2015.12.001. Epub 2015 Dec 28.

引用本文的文献

1
From Womb to Mind: Prenatal Epigenetic Influences on Mental Health Disorders.从子宫到心灵:产前表观遗传学对精神疾病的影响
Int J Mol Sci. 2025 Jun 25;26(13):6096. doi: 10.3390/ijms26136096.
2
Translational potential of GADD45α: biomarker and therapeutic target in age-associated neurodegeneration and longevity.GADD45α的转化潜力:年龄相关性神经退行性变和长寿中的生物标志物及治疗靶点
Biogerontology. 2025 Jun 30;26(4):135. doi: 10.1007/s10522-025-10277-0.
3
Targeting the epigenome with advanced delivery strategies for epigenetic modulators.

本文引用的文献

1
Seamless Genetic Conversion of SMN2 to SMN1 via CRISPR/Cpf1 and Single-Stranded Oligodeoxynucleotides in Spinal Muscular Atrophy Patient-Specific Induced Pluripotent Stem Cells.通过 CRISPR/Cpf1 和单链寡脱氧核苷酸在脊髓性肌萎缩症患者特异性诱导多能干细胞中实现 SMN2 到 SMN1 的无缝基因转换。
Hum Gene Ther. 2018 Nov;29(11):1252-1263. doi: 10.1089/hum.2017.255. Epub 2018 May 9.
2
Epigenetics as biomarkers in autoimmune diseases.表观遗传学作为自身免疫性疾病的生物标志物。
Clin Immunol. 2018 Nov;196:34-39. doi: 10.1016/j.clim.2018.03.011. Epub 2018 Mar 21.
3
Split Cas9, Not Hairs - Advancing the Therapeutic Index of CRISPR Technology.
利用表观遗传调节剂的先进递送策略靶向表观基因组。
Bioeng Transl Med. 2024 Aug 17;10(1):e10710. doi: 10.1002/btm2.10710. eCollection 2025 Jan.
4
Targeting HPV for the prevention, diagnosis, and treatment of cervical cancer.针对人乳头瘤病毒(HPV)进行宫颈癌的预防、诊断和治疗。
J Mol Cell Biol. 2025 May 2;16(10). doi: 10.1093/jmcb/mjae046.
5
Genome editing and kidney health.基因组编辑与肾脏健康。
Clin Kidney J. 2024 Apr 17;17(5):sfae119. doi: 10.1093/ckj/sfae119. eCollection 2024 May.
6
Epigenetic modification: A novel insight into diabetic wound healing.表观遗传修饰:对糖尿病伤口愈合的新见解。
Heliyon. 2024 Mar 13;10(6):e28086. doi: 10.1016/j.heliyon.2024.e28086. eCollection 2024 Mar 30.
7
Revolutionizing therapy with CRISPR/Cas genome editing: breakthroughs, opportunities and challenges.利用CRISPR/Cas基因组编辑革新疗法:突破、机遇与挑战
Front Genome Ed. 2024 Feb 1;6:1342193. doi: 10.3389/fgeed.2024.1342193. eCollection 2024.
8
Involvement of lncRNAs in cancer cells migration, invasion and metastasis: cytoskeleton and ECM crosstalk.长链非编码 RNA 参与肿瘤细胞迁移、侵袭和转移:细胞骨架与细胞外基质的相互作用。
J Exp Clin Cancer Res. 2023 Jul 18;42(1):173. doi: 10.1186/s13046-023-02741-x.
9
From methylation to myelination: epigenomic and transcriptomic profiling of chronic inactive demyelinated multiple sclerosis lesions.从甲基化到髓鞘形成:慢性非活动脱髓鞘多发性硬化病变的表观基因组和转录组分析。
Acta Neuropathol. 2023 Aug;146(2):283-299. doi: 10.1007/s00401-023-02596-8. Epub 2023 Jun 7.
10
Visualizing the Nucleome Using the CRISPR-Cas9 System: From in vitro to in vivo.使用 CRISPR-Cas9 系统可视化核组学:从体外到体内。
Biochemistry (Mosc). 2023 Jan;88(Suppl 1):S123-S149. doi: 10.1134/S0006297923140080.
分 Cas9,不分发——提高 CRISPR 技术的治疗指数。
Biotechnol J. 2018 Sep;13(9):e1700432. doi: 10.1002/biot.201700432. Epub 2018 Feb 2.
4
Turning up the Heat with Therapeutic Epigenome Editing.热疗法的治疗潜力:表观基因组编辑。
Cell Stem Cell. 2018 Jan 4;22(1):10-11. doi: 10.1016/j.stem.2017.12.013.
5
In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.通过CRISPR/Cas9介导的反式表观遗传调控实现体内靶基因激活
Cell. 2017 Dec 14;171(7):1495-1507.e15. doi: 10.1016/j.cell.2017.10.025. Epub 2017 Dec 7.
6
Epigenetic editing of the Dlg4/PSD95 gene improves cognition in aged and Alzheimer's disease mice.Dlg4/PSD95基因的表观遗传编辑改善了老年小鼠和阿尔茨海默病小鼠的认知能力。
Brain. 2017 Dec 1;140(12):3252-3268. doi: 10.1093/brain/awx272.
7
DNA methylation/hydroxymethylation in melanoma.黑色素瘤中的DNA甲基化/羟甲基化
Oncotarget. 2017 May 30;8(44):78163-78173. doi: 10.18632/oncotarget.18293. eCollection 2017 Sep 29.
8
CRISPR/Cas-based screening of long non-coding RNAs (lncRNAs) in macrophages with an NF-κB reporter.基于 CRISPR/Cas 的巨噬细胞长非编码 RNA(lncRNA)筛选与 NF-κB 报告基因
J Biol Chem. 2017 Dec 22;292(51):20911-20920. doi: 10.1074/jbc.M117.799155. Epub 2017 Oct 19.
9
RNA targeting with CRISPR-Cas13.利用CRISPR-Cas13进行RNA靶向
Nature. 2017 Oct 12;550(7675):280-284. doi: 10.1038/nature24049. Epub 2017 Oct 4.
10
DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.使用 CRISPR-Cas SunTag 靶向 DNMT3A 进行 DNA 表观基因组编辑。
Genome Biol. 2017 Sep 18;18(1):176. doi: 10.1186/s13059-017-1306-z.